Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

Glenn J. Bubley, Michael A. Carducci, William L. Dahut, +23

Journal of Clinical Oncology

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel

Olivier Rixe, Waldo Ortuzar, Manuel Álvarez, +4

Biochemical Pharmacology

National Cancer InstituteMedicinePharmacologyCell LinesDrug-resistant Cell Lines +5

Apigenin inhibits VEGF and HIF‐1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways

Jing Fang, Chang Xia, Zongxian Cao, +3

The FASEB Journal

Hif‐1 ExpressionImmunologyTumor BiologyOvarian CancerTranscriptional Regulation +16

Excision repair cross complementing-group 1: Gene expression and platinum resistance (Review) parameters in human breast cancer

Ramin Altaha, Xiaobing Liang, Jing Yu, +1

International Journal of Molecular Medicine

Ercc1 Gene ExpressionPlatinum ResistanceBreast OncologyOncologyOncogenic Agent +13

The impact of disease severity on the informed consent process in clinical research

Monica H. Schaeffer, David S. Krantz, Alison Wichman, +3

The American Journal of Medicine

Clinical SettingsFamily MedicineMedical Decision MakingMedical EthicsHealth Policy +9

Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review)

Gangduo Wang, Eddie Reed, Qingdi Li

Oncology Reports

ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling

Erhong Meng, Aparna Mitra, Kaushlendra Tripathi, +8

PLoS ONE

CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival

Erhong Meng, B.J. Long, Paula A. Sullivan, +5

Clinical & Experimental Metastasis

Stem Cell BiologyMedicineCancer Cell BiologyStem Cell ResearchCancer Biology +7

Phase I Clinical Trial of Oral COL-3, a Matrix Metalloproteinase Inhibitor, in Patients With Refractory Metastatic Cancer

Michelle A. Rudek, William D. Figg, Valerie Dyer, +7

Journal of Clinical Oncology

Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer.

Li Li, Limei Wang, Wei Zhang, +13

PubMed

Serum Vegf LevelsMedicineSerum VegfCancer GrowthGynecology +10